Grace and Formac Pharmaceuticals Announce Successful Clinical Trial Demonstrating the Novel Use of Silica for Drug Delivery – Investors Business Daily

In this study, the bioavailability profile of fenofibrate formulated with silica was compared to the marketed micronized formulation (Lipanthyl ®). The study results show a 54 percent higher bioavailability for the silica formulation than the marketed formulation.

Posted in Uncategorized